A novel X‐linked four‐repeat tauopathy with Parkinsonism and spasticity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The parkinsonian syndromes comprise a highly heterogeneous group of disorders. Although 15 loci are linked to predominantly familial Parkinson's disease (PD), additional PD loci are likely to exist. We recently identified a multigenerational family of Danish and German descent in which five males in three generations presented with a unique syndrome characterized by parkinsonian features and variably penetrant spasticity for which X‐linked disease transmission was strongly suggested (XPDS). Autopsy in one individual failed to reveal synucleinopathy; however, there was a significant four‐repeat tauopathy in the striatum. Our objective was to identify the locus responsible for this unique parkinsonian disorder. Members of the XPDS family were genotyped for markers spanning the X chromosome. Two‐point and multipoint linkage analyses were performed and the candidate region refined by analyzing additional markers. A multipoint LOD max score of 2.068 was obtained between markers DXS991 and DXS993. Haplotype examination revealed an ∼20 cM region bounded by markers DXS8042 and DXS1216 that segregated with disease in all affected males and obligate carrier females and was not carried by unaffected at‐risk males. To reduce the possibility of a false‐positive linkage result, multiple loci and genes associated with other parkinsonian or spasticity syndromes were excluded. In conclusion, we have identified a unique X‐linked parkinsonian syndrome with variable spasticity and four‐repeat tau pathology, and defined a novel candidate gene locus spanning ∼28 Mb from Xp11.2–Xq13.3. © 2010 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
Dickson, D. W., Bergeron, C., Chin, S. S., Duyckaerts, C., Horoupian, D., Ikeda, K., Jellinger, K., Lantos, P. L., Lippa, C. F., Mirra, S. S., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.935 · Cited by 724 · cited 2×
“These aggregates of tau positive glial processes had the appearance of astrocytic plaques, a frequent finding in CBD.29 Consistent with CBD the astrocytic plaque processes were immunopositive with the four-repeat (4R), but not the three-repeat (3R), tau antibody suggesting this was a 4R tauopathy.”
BackgroundCorticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering–Brown, S., Adamson, J., Lees, A. J., Rossor, M. N., Quinn, N. P., Kertesz, A., et al. (2001) · Neurology · doi:10.1212/wnl.56.12.1702 · Cited by 409 · cited 1×
“Similar to CBD and PSP, there was a predominance of the H1 haplotype in this family.(30)”
Result
Cited by
Colacurcio, D. J., & Nixon, R. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.004 · Cited by 548
Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS)
Korvatska, O., Strand, N. S., Berndt, J. D., Strovas, T., Chen, D.-H., Leverenz, J. B., Kiianitsa, K., Mata, I. F., Karakoc, E., Greenup, J. L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt180 · Cited by 140
“ATP6AP2 that produces a similar defect in splicing causes X-linked mental retardation Hedera type (MRXSH; OMIM 300423), a distinct CNS pathology with several overlapping features with XPDS, which include spasticity and seizures (1,8,18).”
BackgroundInfluentialSelf-citationLo, C. H., & Zeng, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00362-0 · Cited by 117
“While LRRK2 and ATP6AP2 mutations are associated with reduction of V-ATPase activity by altering the trafficking and assembly of the enzyme complex [23, 24], ATP13A2 (P5-type ATPase) [25] and ATP10B (P4-type ATPase) [26] mutations cause the accumulation of polyamines and lipids, respectively [25, 26], resulting in ele…”
BackgroundATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration
Hirose, T., Cabrera-Socorro, A., Chitayat, D., Lemonnier, T., Féraud, O., Cifuentes-Diaz, C., Gervasi, N., Mombereau, C., Ghosh, T., Stoica, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci79990 · Cited by 55
“S115S), causing an ATP6AP2/ATP6AP2Δe4 transcript ratio of approximately 50:50, was reported in a family with XPDS and primarily affected the striatum (13, 51).”
Background
Metadata
- Authors
- Poorkaj, P., Raskind, W. H., Leverenz, J. B., Matsushita, M., Zabetian, C. P., Samii, A., Kim, S., Gazi, N., Nutt, J. G., Wolff, J., Yearout, D., Greenup, J. L., Steinbart, E. J., & Bird, T. D.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2010-07-23
- Volume
- 25
- Issue
- 10
- Pages
- 1409-1417
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2113449845
- Cited by
- 27
- References
- 5
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.